Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€138.65

€138.65

-0.680%
-0.95
-0.680%
€143.37
 
02.07.24 / Tradegate WKN: A2PH5P / Symbol: TMDX / Name: Transmedics Group / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Transmedics Group Inc Stock

Transmedics Group Inc shows a slight decrease today, losing -€0.950 (-0.680%) compared to yesterday.
Transmedics Group Inc is currently one of the favorites of our community with 17 Buy predictions and no Sell predictions.
As a result the target price of 143 € shows a slightly positive potential of 3.14% compared to the current price of 138.65 € for Transmedics Group Inc.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Transmedics Group Inc stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Transmedics Group Inc in the next few years

Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Prediction Buy
Perf. (%) 7.27%
Target price 112.176
Change
Ends at 21.06.25

TransMedics Group, Inc. (NASDAQ: TMDX) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $120.00 price target on the stock.
Ratings data for TMDX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 9.13%
Target price 161.963
Change
Ends at 07.06.25

TransMedics Group, Inc. (NASDAQ: TMDX) had its price target raised by analysts at TD Cowen from $130.00 to $175.00. They now have a "buy" rating on the stock.
Ratings data for TMDX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 10.04%
Target price 147.782
Change
Ends at 06.06.25

TransMedics Group, Inc. (NASDAQ: TMDX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $161.00 price target on the stock.
Ratings data for TMDX provided by MarketBeat
Show more